Home
Search Center
Journal List
CMA
Contact US
|
Chinese
You Position:
Home
> Paper
Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy
( views:1, downloads:0 )
Author:
No author available
Journal Title:
Chinese Medical Journal
Issue:
14
DOI:
10.1097/CM9.0000000000002288
Key Word:
No keyword available
Abstract: No abstract available
Reference
[1]Raje, Noopur,Berdeja, Jesus,Lin, Yi,etc.
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
[J].2019,380(18).
[2]Kevin A,Hay.
Cytokine release syndrome and neurotoxicity after CD19 chimeric antigen receptor-modified (CAR-) T cell therapy.
[J].2018.
[3]Locke, Frederick L.,Ghobadi, Armin,Jacobson, Caron A.,etc.
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial
[J].2019,20(1).
[4]Maude, S. L.,Laetsch, T. W.,Buechner, J.,etc.
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
[J].2018,378(5).
WanfangData CO.,Ltd All Rights Reserved
About WanfangData
|
Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:
yiyao@wanfangdata.com.cn